Cell-type-specific effects of genetic variation on chromatin accessibility during human neuronal differentiation
- PMID: 34017130
- PMCID: PMC8254789
- DOI: 10.1038/s41593-021-00858-w
Cell-type-specific effects of genetic variation on chromatin accessibility during human neuronal differentiation
Abstract
Common genetic risk for neuropsychiatric disorders is enriched in regulatory elements active during cortical neurogenesis. However, it remains poorly understood as to how these variants influence gene regulation. To model the functional impact of common genetic variation on the noncoding genome during human cortical development, we performed the assay for transposase accessible chromatin using sequencing (ATAC-seq) and analyzed chromatin accessibility quantitative trait loci (QTL) in cultured human neural progenitor cells and their differentiated neuronal progeny from 87 donors. We identified significant genetic effects on 988/1,839 neuron/progenitor regulatory elements, with highly cell-type and temporally specific effects. A subset (roughly 30%) of chromatin accessibility-QTL were also associated with changes in gene expression. Motif-disrupting alleles of transcriptional activators generally led to decreases in chromatin accessibility, whereas motif-disrupting alleles of repressors led to increases in chromatin accessibility. By integrating cell-type-specific chromatin accessibility-QTL and brain-relevant genome-wide association data, we were able to fine-map and identify regulatory mechanisms underlying noncoding neuropsychiatric disorder risk loci.
Conflict of interest statement
Declaration of Interests
The authors declare no competing interests.
Figures
References
-
- Grasby KL et al. The genetic architecture of the human cerebral cortex. bioRxiv 399402 (2018) doi: 10.1101/399402. - DOI
Publication types
MeSH terms
Substances
Grants and funding
- R01 MH110928/MH/NIMH NIH HHS/United States
- P30 ES010126/ES/NIEHS NIH HHS/United States
- R01 MH120125/MH/NIMH NIH HHS/United States
- R56 MH114901/MH/NIMH NIH HHS/United States
- U01 MH103365/MH/NIMH NIH HHS/United States
- R01 MH110905/MH/NIMH NIH HHS/United States
- R21 MH109956/MH/NIMH NIH HHS/United States
- P30 NS045892/NS/NINDS NIH HHS/United States
- U01 MH103339/MH/NIMH NIH HHS/United States
- R01 MH110920/MH/NIMH NIH HHS/United States
- U01 MH116487/MH/NIMH NIH HHS/United States
- R21 MH105881/MH/NIMH NIH HHS/United States
- R01 MH110921/MH/NIMH NIH HHS/United States
- R01 MH110926/MH/NIMH NIH HHS/United States
- U01 MH116488/MH/NIMH NIH HHS/United States
- U01 MH116438/MH/NIMH NIH HHS/United States
- U01 MH116442/MH/NIMH NIH HHS/United States
- R01 MH094714/MH/NIMH NIH HHS/United States
- R01 MH117292/MH/NIMH NIH HHS/United States
- R21 MH103877/MH/NIMH NIH HHS/United States
- U01 MH116489/MH/NIMH NIH HHS/United States
- P50 HD103573/HD/NICHD NIH HHS/United States
- R01 MH110927/MH/NIMH NIH HHS/United States
- P30 DK034987/DK/NIDDK NIH HHS/United States
- U01 MH116441/MH/NIMH NIH HHS/United States
- R56 MH114899/MH/NIMH NIH HHS/United States
- U01 MH103392/MH/NIMH NIH HHS/United States
- R01 MH117291/MH/NIMH NIH HHS/United States
- R01 MH117293/MH/NIMH NIH HHS/United States
- P50 CA058223/CA/NCI NIH HHS/United States
- R01 MH109677/MH/NIMH NIH HHS/United States
- U01 MH103346/MH/NIMH NIH HHS/United States
- R37 MH060233/MH/NIMH NIH HHS/United States
- U54 EB020403/EB/NIBIB NIH HHS/United States
- R56 MH114911/MH/NIMH NIH HHS/United States
- P30 AI028697/AI/NIAID NIH HHS/United States
- R00 MH102357/MH/NIMH NIH HHS/United States
- R01 MH111721/MH/NIMH NIH HHS/United States
- U01 MH103340/MH/NIMH NIH HHS/United States
- R21 MH102791/MH/NIMH NIH HHS/United States
- R01 MH105898/MH/NIMH NIH HHS/United States
- R01 MH118349/MH/NIMH NIH HHS/United States
- R21 MH105853/MH/NIMH NIH HHS/United States
- R01 MH109715/MH/NIMH NIH HHS/United States
- U01 MH116492/MH/NIMH NIH HHS/United States
- P50 MH106934/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
